Clinical Trials for Primary Peritoneal Carcinosarcoma

Find clinical trials for primary peritoneal carcinosarcoma. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

NCT ID: NCT05920798

This clinical trial is studying a new treatment approach for women with advanced ovarian, fallopian tube, or primary peritoneal cancer. Researchers want to see how well a combination of a special t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Scottsdale, Arizona, United States, Jacksonville, Florida, United States +1 more

APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion

NCT ID: NCT04919629

This clinical trial is studying new treatment options for women with recurrent ovarian, fallopian tube, or primary peritoneal cancer, particularly in cases where there is a buildup of fluid and can...

Recruiting

Phase: PHASE2 Type: interventional Locations: Buffalo, New York, United States

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

NCT ID: NCT06639074

The FAROUT trial is a research study that is testing a new treatment for women with advanced ovarian, fallopian tube, or primary peritoneal cancer, specifically those at stage III or IV. In this tr...

Recruiting

Phase: PHASE2 Type: interventional Locations: Scottsdale, Arizona, United States, Jacksonville, Florida, United States +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions